CatalystPit

VXRTVaxart, Inc.

OTC · Biological Products, (No Diagnostic Substances)
Last close $0.45 · 2026-09-30
ABOUT
ExchangeOTC
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$109.28M
RECENT INSIDER TRADES
  • 2026-07-17 · Watson W. Mark (Director) · OTHER
  • 2026-07-17 · HERON ELAINE J (Director) · OTHER
  • 2026-07-17 · BREITMEYER JAMES B (Director) · OTHER
  • 2026-07-17 · Wheadon David E. (Director) · OTHER
  • 2026-05-26 · Watson W. Mark (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders8
Shares held2,041,684
Value$1.38M
Percent of shares outstanding0.84%
As of quarter end2026-06-30
RECENT NEWS
  • Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
  • Vaxart presents at H.C. Wainwright 28th Annual Global Investment Conference
  • Vaxart presents oral vaccine progress at H.C. Wainwright conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Vaxart, Inc. (VXRT) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit